Monday, February 04, 2013

The use of novel anticoagulants in atrial fibrillation: superior to vitamin K antagonism in this meta-analysis

Note that the analysis included, in addition to dabigatran and rivaroxaban, two others not currently approved in the US.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)